Company news

OncoTherapy Science, Inc. news in 2022

OncoTherapy Science, Inc.'s news releases, calls and decks from 2022, newest first.

View company

Announcement of the Presentation of Interim Results for Phase I Clinical Study of a Combination of OTSGC-A24 and Immune Checkpoint Inhibitor in Patients with Gastric Cancer

September 12, 2022